Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
Anika Therapeutics (NASDAQ: ANIK) is set to release its fourth quarter and year-end 2021 financial results on March 8, 2022, after market close. The company will also host an investor conference call at 5:00 p.m. ET the same day to discuss these results and business highlights. Interested parties can join the call by dialing the provided numbers or accessing a live audio webcast through the Investor Relations section of Anika's website, where a slide presentation will also be available.
- None.
- None.
BEDFORD, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its fourth quarter and year-end 2021 financial results after the close of the market on Tuesday, March 8, 2022 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.
The conference call can be accessed by dialing 1-800-437-2398 (toll-free domestic) or 1-856-344-9206 (international) and providing the conference ID number 1077520. A live audio webcast will be available in the Investor Relations section of Anika's website, www.anika.com. An accompanying slide presentation also can be accessed via the Anika website. The call will be archived and accessible on the same website shortly after its conclusion.
About Anika
Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. We partner with physicians to understand what they need most to treat their patients and we develop minimally invasive products that restore active living for people around the world. We are committed to leading in high opportunity spaces within orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair and bone preserving joint technologies. Anika is headquartered in Massachusetts with operations in the United States and Europe. For more information, please visit www.anika.com.
ANIKA, ANIKA THERAPEUTICS and the Anika logo are registered trademarks of Anika Therapeutics, Inc.
For Investor Inquiries:
Anika Therapeutics, Inc.
Mark Namaroff, 781-457-9287
Executive Director, Investor Relations and Corporate Communications
investorrelations@anika.com
FAQ
When will Anika Therapeutics release its fourth quarter financial results?
What time is the investor conference call for Anika Therapeutics?
How can I access the investor conference call for Anika Therapeutics?
Where can I find the slide presentation related to Anika's financial results?
